Results 131 to 140 of about 1,542,864 (150)
Some of the next articles are maybe not open access.

The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4’-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats

Neuroscience, 2001
Repeated administration of amphetamine-like psychostimulants produce a progressive and long-lasting hypersensitivity to their behavioural effects known as behavioural sensitization. Previous studies have shown that administration of the purinergic P2 receptor agonist 2-methylthio ATP into the nucleus accumbens of rats raises the extracellular level of ...
H, Kittner, U, Krügel, P, Illes
openaire   +2 more sources

Antimalarial and Plasmodium falciparum Serpentine Receptor 12 Targeting Effect of FDA Approved Purinergic Receptor Antagonist

Journal of Biomolecular Structure and Dynamics, 2023
Shailja Singh   +2 more
exaly  

Update on Novel Purinergic P2X3 and P2X2/3 Receptor Antagonists and Their Potential Therapeutic Applications

Expert Opinion on Therapeutic Patents, 2019
Aleix Martí Navia   +2 more
exaly  

Temporary Remissionsin Acute Leukemiain Children Producedby Folic Acid Antagonist…Aminopterin

Ca-A Cancer Journal for Clinicians, 1974
Sidney Farber, S Farber
exaly  

Purinergic Receptor P2X7: A Novel Target for Anti-Inflammatory Therapy

Bioorganic and Medicinal Chemistry, 2014
Om Silakari   +2 more
exaly  

Home - About - Disclaimer - Privacy